News

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...
The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...
The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...
A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...